- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02164695
Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction (CAPRI)
Cardioprotective Effects of Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
To evaluate whether remote ischemic per-conditioning (RIPC) can reduce infarct size in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (PPCI) within 12 hours of symptoms onset.
- Control group: PPCI only
- Study group: PPCI + RIPC
Primary endpoint: Infarct size measured by contrast-enhanced cardiac magnetic resonance (CMR) at 6 months after the index procedure
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
ST-elevation myocardial infarction (STEMI) is a leading cause of mortality and morbidity. Early myocardial reperfusion with either of thrombolytic therapy or primary percutaneous coronary intervention (PPCI) is the most effective strategy for reducing the size of a myocardial infarct and improving the clinical outcome. Although this process can restore blood flow to the ischemic myocardium, it can induce injury. This phenomenon termed myocardial reperfusion injury can paradoxically reduce the beneficial effects of myocardial reperfusion. The pre-clinical study in animal models of acute myocardial infarction suggests that lethal reperfusion injury accounts for up to 50% of the final size of a myocardial infarct.
Remote ischemic conditioning uses brief ischemia and reperfusion of a distant organ to protect the myocardium. In animal study, remote ischemic postconditioning seems to be more effective than local postconditioning in experimental myocardial infarction.Bøtker et al. has reported remote ischemic preconditioning before hospital admission increase myocardial salvage in patients with acute myocardial infarction.
The objective of this study is to evaluate whether remote ischemic per-conditioning (RIPC) can reduce late infarct size in patients with STEMI treated with PPCI within 12 hours of symptoms onset. To test this hypothesis, we will randomize patients into PPCI + RIPC or PPCI alone. We will evaluate marker of reperfusion injury using contrast cardiac magnetic resonance image.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gangwon
-
Wonju, Gangwon, Korea, Republic of, 220060
- WonJu Severance Christian Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age >19 years
- Presenting within 12 hours of symptom onset
- >20 min of chest pain
- ST-elevation myocardial infarction defined as ST-segment elevation (>0.1 mV) in at least 2 contiguous precordial leads
Exclusion Criteria:
- Previous myocardial infarction
- Presence of chronic total occlusion
- Evidence of retrograde filling by collaterals at coronary angiography (Rentrop 2 or 3 collateral flow)
- Severe multi-vessel coronary artery disease to require further interventions before follow-up CMR
- Cardiac arrest before randomization
- Arrhythmias requiring external electric shock before randomization
- Unwillingness to participate
- External electric shock for cardioversion within first 3 days
- Cardiac surgery within first 3 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: PPCI plus RIPC
The patients randomized to PPCI plus RIPC group will receive RIPC during PPCI.
|
All patients will be prepared with an upper-arm blood pressure cuff before arterial puncture (contralateral in case of radial access).
In patients allocated into PPCI plus RIPC group, the protocol will be started immediately after cuff preparation.
Upper-arm will be exposed to 4 cycles of ischemia/reperfusion, each obtained by 5 min cuff inflation at 200mmHg, followed by 5 min complete deflation.
|
|
SHAM_COMPARATOR: PPCI only
The patients randomized to PPCI only group will receive PPCI only but the sham procedure of RIPC.
|
All patients randomized to PPCI only arm, the blood pressure cuff will be applied to the arm or the calf but will not be inflated.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Infarct size measured by contrast-enhanced cardiac magnetic resonance
Time Frame: 6 months after index procedure
|
Infarct size will be assessed on late-contrast images (≈10 min after gadolinium administration) by manually tracing the hyperintense area in each short-axis slice.
|
6 months after index procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Enzymatic Infarct Size
Time Frame: 1 to 5 days after index procedure
|
Enzymatic infarct size will be assessed by the area under the curve of creatine kinase-myocardial band (CK-MB) and troponin I (TnI) release.
Blood samples will be collected before PCI and every day after index PPCI.
Area under the curve of CK-MB and troponin I release will be expressed in arbitrary units and calculated with the trapezoidal method.
|
1 to 5 days after index procedure
|
|
Resolution of ST-segment deviation
Time Frame: 1 to 5 days after index procedure
|
ST-segment deviation score will be measured in 12-lead electrocardiograms, calculated as the sum (in millimeters) of ST-segment deviation (elevation or depression) at 80 ms after the J-point in all 12 leads.
ST-segment deviation score will be measured at presentation and 30 min after PCI, by 2 physicians blinded as to the patients' data, and the mean value of the 2 assessments will be used.
ST-segment resolution will be calculated as a percentage: ratio of the reduction in ST-segment deviation score from presentation to half an hour after PCI over the ST-segment deviation score at presentation × 100% (i.e., [(ST-segment deviation at presentation - ST-segment deviation post-PCI)/ST-segment deviation at presentation] × 100%).
Full ST-segment resolution will be defined as 80% or more reduction of ST-segment deviation score.
|
1 to 5 days after index procedure
|
|
Acute kidney injury
Time Frame: 1 to 3 days after index procedure
|
Acute kidney injury will be defined as an absolute increase in serum creatinine of ≥0.5 mg/dl or a relative increase of ≥25% compared with baseline within 96 h after PCI (the maximal measured concentration of serum creatinine during these 96 h will be used).
Relative reduction in estimated glomerular filtration rate (eGFR), calculated with the Modification of Diet in Renal Disease formula, within 96 h after PCI will be assessed.
|
1 to 3 days after index procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Young Jin Youn, MD, Yonsei Univeristy Wonju College of Medicine
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR314003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ST-segment Elevation Myocardial Infarction
-
Inha University HospitalCompletedST Segment Elevation Myocardial Infarction | Non-ST Segment Elevation Myocardial InfarctionKorea, Republic of
-
University Hospital, Basel, SwitzerlandUniversity of BaselRecruitingNSTEMI - Non-ST Segment Elevation MI | ST-segment Elevation Myocardial Infarction (STEMI) | Acute Cardiovascular DiseaseSwitzerland
-
RenJi HospitalCompletedST Segment Elevation Myocardial Infarction
-
Dong-A UniversityTerminatedST-Segment Elevation Myocardial InfarctionKorea, Republic of
-
Azienda Ospedaliera San Camillo ForlaniniUnknownST Segment Elevation Myocardial InfarctionItaly
-
Jinan Central HospitalUnknownST-Segment Elevation Myocardial InfarctionChina
-
Haseki Training and Research HospitalCompletedAcute Coronary Syndrome | ST-segment Elevation Myocardial Infarction (STEMI) | Major Adverse Cardiac Events | Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)Turkey
-
Assiut UniversityNot yet recruitingST-segment Elevation Myocardial Infarction (STEMI)
-
Assiut UniversityUnknownST-segment Elevation Myocardial Infarction (STEMI)
-
Hellenic Cardiovascular Research SocietyCompletedMyocardial Infarction | ST Segment Elevation Myocardial Infarction (STEMI)Greece
Clinical Trials on PPCI plus RIPC
-
Assiut UniversityNot yet recruiting
-
Penn State UniversityCompletedAlzheimer Disease and Related DementiasUnited States
-
Helsinki University Central HospitalAcademy of Finland; Finska Läkaresällskapet (funding); Helsinki University Hospital...Recruiting
-
Catharina Ziekenhuis EindhovenRigshospitalet, Denmark; Mid and South Essex NHS Foundation Trust; Abbott; Örebro... and other collaboratorsActive, not recruitingReperfusion Injury | Acute Myocardial InfarctionNetherlands
-
Oladipupo Olafiranye, MD, MSNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedContrast-induced Acute Kidney InjuryUnited States
-
Universität MünsterRecruitingSepsis | Acute Kidney Injury | Critically IllGermany
-
Seoul National University HospitalCompletedIschemic Reperfusion Injury | Radiotherapy | Other Reconstructive SurgeryKorea, Republic of
-
Liverpool John Moores UniversityCompletedCardiovascular Disease RiskUnited Kingdom
-
Assiut UniversityUnknown
-
Assiut UniversityNot yet recruiting